The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 29, 2019

Filed:

Dec. 20, 2013
Applicant:

Ucb Biopharma Sprl, Brussels, BE;

Inventors:

Emma Dave, Slough, GB;

Sam Philip Heywood, Slough, GB;

David Paul Humphreys, Slough, GB;

Assignee:

UCB BIOPHARMA SPRL, Brussels, BE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); C07K 16/46 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
C07K 16/468 (2013.01); C07K 16/18 (2013.01); C07K 16/2878 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/624 (2013.01); C07K 2317/64 (2013.01); C07K 2317/92 (2013.01); C07K 2319/00 (2013.01);
Abstract

The present disclosure relates to a multi-specific antibody molecule comprising or consisting of three polypeptides: a) a polypeptide chain of formula (I): (Vxx)Vx-Cx-X-V; and b) a polypeptide chain of formula (II): (Vyy)Vy-Cy c) a polypeptide of formula (III): Vwherein Vx represents a variable domain, Vxx represents a variable domain, Cx represents a constant region, X represents a linker, V represents a variable domain, Vy represents a variable domain, Vyy represents a variable domain, Cy represents a constant region, Vrepresents a variable domain,independently represents 0 or 1, wherein the polypeptide chain of formula (I) and the polypeptide chain of formula (II) is aligned such that the constant regions Cx and Cy are paired and the variable domains Vx and Vy are paired to form a binding domain and optionally a disulphide bond is present between V and V, in particular where a disulphide bond is present. The disclosure also extends to pharmaceutical formulation comprising the construct, DNA encoding the constructs and vectors comprising same. The disclosure further extends to a method of expressing the constructs, for example in a host cell and methods for formulating same as a pharmaceutical composition. The disclosure also relates to use of the constructs and formulations in treatment.


Find Patent Forward Citations

Loading…